Lv1
36 积分 2024-01-22 加入
JOSD1 drives hepatocellular carcinoma malignancy by modulating the ubiquitination-lactylation switch on PGAM1
2小时前
已完结
Landscape screening identifies the lactate-modifying enzyme AARS2 as a master regulator and therapeutic target in hepatocellular carcinoma
2小时前
已完结
Trogocytosis-orchestrated CLDN18.2-“dressed” CD8 + T cells drive pancreatic cancer progression via glucose metabolic reprogramming-induced cytotoxicity debilitation and systematic immune senescence cascade
3个月前
已完结
Adipokines: masterminds of metabolic inflammation
3个月前
已完结
Obesity-driven inflammation and cancer risk: A comprehensive review
3个月前
已完结
Gestational Diabetes Mellitus
4个月前
已完结
Insulin as an immunomodulatory hormone
5个月前
已完结
Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management
5个月前
已完结
Obesity, insulin resistance, NASH and hepatocellular carcinoma
5个月前
已完结
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
5个月前
已完结
皖公网安备34019202002308
